HP and liver disorder: Thus, we designed our study to address these issues by evaluating a larger cohort, and we applied site-specific glycoproteomics methods in order to characterize the alteration in glycan composition at each Hp glycosite separately as the condition progresses from various liver diseases to early- and late-stage HCC.